☰

Diane M. Jaworski - Publications

Affiliations: 
Univ. of Vermont College of Medicine, Burlington, VT, United States 
Area:
Developmental Neuroscience
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Carr FE, Tai PW, Barnum MS, Gillis NE, Evans KG, Taber TH, White JH, Tomczak JA, Jaworski DM, Zaidi SK, Lian JB, Stein JL, Stein GS. Thyroid Hormone Receptor β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A novel signaling pathway in thyroid cancer. Endocrinology. en20152046. PMID 27253998 DOI: 10.1210/En.2015-2046  0.388
2015 Jaworski DM, Namboodiri AM, Moffett JR. Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy. Journal of Cellular Biochemistry. PMID 26251955 DOI: 10.1002/jcb.25305  0.307
2015 Long PM, Tighe SW, Driscoll HE, Fortner KA, Viapiano MS, Jaworski DM. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. Journal of Cellular Physiology. 230: 1929-43. PMID 25573156 DOI: 10.1002/Jcp.24927  0.65
2015 Kelwick R, Wagstaff L, Decock J, Roghi C, Cooley LS, Robinson SD, Arnold H, Gavrilović J, Jaworski DM, Yamamoto K, Nagase H, Seubert B, Krüger A, Edwards DR. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15. International Journal of Cancer. Journal International Du Cancer. 136: E14-26. PMID 25099234 DOI: 10.1002/Ijc.29129  0.486
2014 Tsen AR, Long PM, Driscoll HE, Davies MT, Teasdale BA, Penar PL, Pendlebury WW, Spees JL, Lawler SE, Viapiano MS, Jaworski DM. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. International Journal of Cancer. Journal International Du Cancer. 134: 1300-10. PMID 23996800 DOI: 10.1002/Ijc.28465  0.647
2013 Long PM, Tighe SW, Driscoll HE, Moffett JR, Namboodiri AM, Viapiano MS, Lawler SE, Jaworski DM. Acetate supplementation induces growth arrest of NG2/PDGFRα-positive oligodendroglioma-derived tumor-initiating cells. Plos One. 8: e80714. PMID 24278309 DOI: 10.1371/Journal.Pone.0080714  0.655
2013 Long PM, Moffett JR, Namboodiri AM, Viapiano MS, Lawler SE, Jaworski DM. N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. The Journal of Biological Chemistry. 288: 26188-200. PMID 23884408 DOI: 10.1074/Jbc.M113.487553  0.681
2013 Thirkettle S, Decock J, Arnold H, Pennington CJ, Jaworski DM, Edwards DR. Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells. The Journal of Biological Chemistry. 288: 16282-94. PMID 23632023 DOI: 10.1074/Jbc.M113.464230  0.437
2012 Long PM, Tsen A, Moffett JR, Namboodiri AMA, Viapiano MS, Jaworski DM. Abstract 3481: Dietary acetate supplementation as a means of inducing glioma stem cell growth arrest Cancer Research. 72: 3481-3481. DOI: 10.1158/1538-7445.Am2012-3481  0.661
2011 Kandalam V, Basu R, Moore L, Fan D, Wang X, Jaworski DM, Oudit GY, Kassiri Z. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress. Circulation. 124: 2094-105. PMID 21986284 DOI: 10.1161/CIRCULATIONAHA.111.030338  0.427
2011 Jaworski DM, Sideleva O, Stradecki HM, Langlois GD, Habibovic A, Satish B, Tharp WG, Lausier J, Larock K, Jetton TL, Peshavaria M, Pratley RE. Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice. Endocrinology. 152: 1300-13. PMID 21285317 DOI: 10.1210/en.2010-1029  0.404
2011 Stradecki HM, Jaworski DM. Hyperphagia and leptin resistance in tissue inhibitor of metalloproteinase-2 deficient mice. Journal of Neuroendocrinology. 23: 269-81. PMID 21175899 DOI: 10.1111/j.1365-2826.2010.02105.x  0.381
2011 Long PM, Stradecki HM, Minturn JE, Wesley UV, Jaworski DM. Differential aminoacylase expression in neuroblastoma. International Journal of Cancer. Journal International Du Cancer. 129: 1322-30. PMID 21128244 DOI: 10.1002/Ijc.25798  0.431
2011 Kelwick R, Wagstaff L, Decock J, Arnold H, Pennington C, Jaworski D, Edwards. An analysis of the functional consequences of ADAMTS15 expression reveals an anti migratory effect in mammary cancer cell lines F1000research. 2. DOI: 10.7490/F1000Research.1081.1  0.332
2010 Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15337-57. PMID 21084591 DOI: 10.1523/Jneurosci.3467-10.2010  0.429
2010 Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circulation Research. 106: 796-808. PMID 20056917 DOI: 10.1161/CIRCRESAHA.109.209189  0.414
2010 Wagstaff L, Kelwick R, Decock J, Arnold H, Pennington C, Jaworski D, Edwards D. ADAMTS15 metalloproteinase inhibits breast cancer cell migration. Breast Cancer Research. 12: 15. DOI: 10.1186/Bcr2512  0.407
2008 Lluri G, Langlois GD, Soloway PD, Jaworski DM. Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro. Experimental Cell Research. 314: 11-24. PMID 17678891 DOI: 10.1016/j.yexcr.2007.06.007  0.702
2007 Jaworski DM, Beem-Miller M, Lluri G, Barrantes-Reynolds R. Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2. Physiological Genomics. 28: 168-78. PMID 16985004 DOI: 10.1152/physiolgenomics.00160.2006  0.688
2006 Lluri G, Langlois GD, McClellan B, Soloway PD, Jaworski DM. Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a beta1 integrin-mediated mechanism. Journal of Neurobiology. 66: 1365-77. PMID 16967503 DOI: 10.1002/neu.20315  0.664
2006 Jaworski DM, Pérez-Martínez L. Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals. Journal of Neurochemistry. 98: 234-47. PMID 16805810 DOI: 10.1111/j.1471-4159.2006.03855.x  0.465
2006 Jaworski DM, Soloway P, Caterina J, Falls WA. Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits. Journal of Neurobiology. 66: 82-94. PMID 16216006 DOI: 10.1002/Neu.20205  0.419
2006 LLURI G, LANGLOIS G, SOLOWAY P, JAWORSKI D. TIMP_2 regulates myogenesis in vitro Matrix Biology. 25: S45-S46. DOI: 10.1016/J.MATBIO.2006.08.126  0.674
2005 Lluri G, Jaworski DM. Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation. Muscle & Nerve. 32: 492-9. PMID 16003733 DOI: 10.1002/mus.20383  0.697
2005 Jaworski DM, Boone J, Caterina J, Soloway P, Falls WA. Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice. Brain Research. 1051: 81-9. PMID 15979591 DOI: 10.1016/J.Brainres.2005.05.057  0.386
2005 Pérez-Martínez L, Jaworski DM. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 4917-29. PMID 15901773 DOI: 10.1523/JNEUROSCI.5066-04.2005  0.495
2000 Fager N, Jaworski DM. Differential spatial distribution and temporal regulation of tissue inhibitor of metalloproteinase mRNA expression during rat central nervous system development. Mechanisms of Development. 98: 105-9. PMID 11044612 DOI: 10.1016/S0925-4773(00)00437-8  0.521
2000 Jaworski DM, Fager N. Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development. Journal of Neuroscience Research. 61: 396-408. PMID 10931526 DOI: 10.1002/1097-4547(20000815)61:4<396::AID-JNR6>3.0.CO;2-S  0.505
2000 Jaworski DM. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell and Tissue Research. 300: 219-30. PMID 10867818 DOI: 10.1007/S004410000184  0.4
2000 Jaworski DM, Proctor MD. Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. Brain Research. Developmental Brain Research. 120: 27-39. PMID 10727727 DOI: 10.1016/S0165-3806(99)00192-3  0.388
2000 Jaworski DM. Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system. Brain Research. 860: 174-7. PMID 10727639 DOI: 10.1016/S0006-8993(00)02035-7  0.456
2000 Jaworski DM. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia. 30: 199-208. PMID 10719361 DOI: 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#  0.47
1999 Jaworski DM, Kelly GM, Hockfield S. Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican. Experimental Neurology. 157: 327-37. PMID 10364444 DOI: 10.1006/exnr.1999.7062  0.681
1998 Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 2370-6. PMID 9502798  0.651
1998 Zhang H, Kelly G, Zerillo C, Jaworski DM, Hockfield S. Expression of a Cleaved Brain-Specific Extracellular Matrix Protein Mediates Glioma Cell Invasion In Vivo The Journal of Neuroscience. 18: 2370-2376. DOI: 10.1523/Jneurosci.18-07-02370.1998  0.672
1996 Jaworski DM, Kelly GM, Piepmeier JM, Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Research. 56: 2293-8. PMID 8625302  0.354
1996 Jaworski DM, Kelly GM, Hockfield S. The CNS-specific hyaluronan binding protein, BEHAB, is expressed during periods of glial cell generation and motility Seminars in the Neurosciences. 8: 391-396. DOI: 10.1006/smns.1996.0047  0.67
1995 Jaworski DM, Kelly GM, Hockfield S. The CNS-specific hyaluronan-binding protein BEHAB is expressed in ventricular zones coincident with gliogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1352-62. PMID 7869103  0.67
1995 Jaworski DM, Kelly GM, Hockfield S. The CNS-specific hyaluronan-binding protein BEHAB is expressed in ventricular zones coincident with gliogenesis The Journal of Neuroscience. 15: 1352-1362. DOI: 10.1523/Jneurosci.15-02-01352.1995  0.689
1994 Jaworski DM, Kelly GM, Hockfield S. BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan-binding proteins that is restricted to the brain. The Journal of Cell Biology. 125: 495-509. PMID 7512973 DOI: 10.1083/JCB.125.2.495  0.653
Show low-probability matches.